73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Treatment of advanced non-small cell lung cancer with driver mutations

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved
US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ
Shedding light—literally—on resistance to radiation therapy

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Global disease burden related to nonmelanoma skin cancer explored

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel
Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by WileyMelanoma. Credit: Wikimedia Commons/National Cancer InstituteAlthough melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is
Liver cancer cases and deaths projected to rise by more than 55% by 2040

Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t

Liver cancer cases and deaths projected to rise by more than 55% by 2040

by ElsevierMain findings on the global burden of liver cancer in 2020 and predictions to 2040. Credit:Journal of HepatologyA new analysis reveals that primary liver cancer was among t
New wearable device measures the changing size of tumors below the skin

New wearable device measures the changing size of tumors below the skin

by Andrew Myers,Georgia Institute of TechnologyFAST sensor. Credit: Stanford UniversityEngineers at the Georgia Institute of Technology and Stanford University have created a small, autonomous d

New wearable device measures the changing size of tumors below the skin

by Andrew Myers,Georgia Institute of TechnologyFAST sensor. Credit: Stanford UniversityEngineers at the Georgia Institute of Technology and Stanford University have created a small, autonomous d
Cancer biology graduate student travels 'ROCKy' road toward a cure for post-radiation dry mouth

Cancer biology graduate student travels 'ROCKy' road toward a cure for post-radiation dry mouth

by University of ArizonaWen Yu "Amy" Wong. Credit: Gaius J. AugustusThe United States is in the midst of a head-and-neck cancer epidemic. Although survival rates are relatively high—aft

Cancer biology graduate student travels 'ROCKy' road toward a cure for post-radiation dry mouth

by University of ArizonaWen Yu "Amy" Wong. Credit: Gaius J. AugustusThe United States is in the midst of a head-and-neck cancer epidemic. Although survival rates are relatively high—aft
The long-term financial toll of breast cancer

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can